Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor-Reference-Cited by-同舟云学术

Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor

Published:2012-01 Issue: Volume:1431 Page:86-96
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Whone Alan L.,Kemp Kevin,Sun Mingzhu,Wilkins Alastair,Scolding Neil J.

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference54 articles.

1. Human bone marrow stroma cells display certain neural characteristics and integrate in the subventricular compartment after injection into the liquor system;Arnhold;Eur. J. Cell Biol.,2006

2. Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols;Barzilay;Stem Cells Dev.,2008

3. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain;Beck;Nature,1995

4. A twist of fate;Blau;Nature,2002

5. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease;Bouchez;Neurochem. Int.,2008

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of primary and repeated therapy courses of Parkinson’s disease with autologous mesenchymal stromal cells in the long-term period;Proceedings of the National Academy of Sciences of Belarus, Medical series;2024-03-04

2. Restorative Action of Stem Cells in Neuroretinal Degenerations as a Possible Application by Ocular Mesenchymal Autograft;Comprehensive Hematology and Stem Cell Research;2024

3. Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials;Stem Cell Research & Therapy;2023-05-04

4. Stem Cell-based and Advanced Therapeutic Modalities for Parkinson’s Disease: A Risk-effectiveness Patient-centered Analysis;Current Neuropharmacology;2022-12

5. Transcription factor EB-mediated mesenchymal stem cell therapy induces autophagy and alleviates spinocerebellar ataxia type 3 defects in neuronal cells model;Cell Death & Disease;2022-07-18